Gepotidacin
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 135 publications
Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea.
Journal: The Annals of pharmacotherapy
Published: April 11, 2026
Pivmecillinam (Pivya) for uncomplicated UTI.
Journal: The Medical letter on drugs and therapeutics
Published: April 10, 2026
Public contributions to the development of antibiotics: two successful and two failed investments.
Journal: Journal of pharmaceutical policy and practice
Published: April 01, 2026
Blujepa: A promising step forward in the fight against antibiotic-resistant UTIs.
Journal: JPMA. The Journal of the Pakistan Medical Association
Published: March 14, 2026
Stepwise evolution and clonal enrichment of gepotidacin resistance in Neisseria gonorrhoeae.
Journal: Antimicrobial agents and chemotherapy
Published: March 11, 2026
Two new drugs for gonorrhea.
Journal: The Medical letter on drugs and therapeutics
Published: March 07, 2026
Bacterial DNA topoisomerase IV and DNA gyrase inhibitors: history of the quinolones, their clinical usage and potential alternatives for the future.
Journal: The Journal of antimicrobial chemotherapy
Published: February 19, 2026
Genetic background modulates zoliflodacin and gepotidacin cross-resistance and fitness in Neisseria gonorrhoeae.
Journal: The Journal of infectious diseases
Published: January 22, 2026
The Drug Update: Recent drug approvals, winter 2026 edition.
Journal: The Nurse practitioner
Published: January 22, 2026
2025 New Drug Update (Part 2): Recent Approvals and Clinical Implications.
Journal: The Senior care pharmacist
Published: January 20, 2026
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review.
Journal: British journal of pharmacology
Published: January 16, 2026
Last Updated: 04/28/2026